Advertisement

Cancer Chemotherapy and Pharmacology

, Volume 28, Issue 1, pp 22–26 | Cite as

High-performance liquid chromatography assay of bleomycin in human plasma and rat hepatocytes in culture

  • Rachid Mahdadi
  • Abdelraouf Kenani
  • Nicole Pommery
  • Jean Pommery
  • Jean Pierre Hénichart
  • Michel Lhermitte
Original Articles Bleomycin, HPLC, Rat Hepatocytes, Plasma

Summary

A sensitive and rapid linear-gradient, ionpaired, reversed-phase high-performance liquid chromatography technique using fluorescence detection was developed to quantify bleomycin (BLM) metabolites in the plasma of patients undergoing BLM therapy and in rat hepatocytes that had previously been incubated with 5×10−5m BLM. We could detect about 70 ng/ml using this procedure. BLM metabolites were assayed in the supernatant fractions of precipitated human plasma and in pellets of rat hepatocytes. Metabolite concentrations were below the level of detection in human plasma samples. In hepatocyte pellets, metabolites such as deamido-BLM A2 and deamido-BLM B2 were detected, indicating that isolated rat hepatocytes in culture can metabolize BLM analogues to the corresponding deamido-BLMs. The high-performance liquid chromatography procedure developed during this work can be used to study the metabolism of BLM in cell-culture systems.

Keywords

Plasma Sample Human Plasma Bleomycin Fluorescence Detection Metabolite Concentration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Akiyama SI, Kuwano M (1981) Isolation and preliminary characterization of bleomycin-resistant mutants from Chinese hamster ovary cells. J Cell Physiol 107:147Google Scholar
  2. 2.
    Akiyama SI, Ikezaki K, Kuramochi H, Takahashi K, Kuwano M (1981) Bleomycin-resistant cells contain increased bleomycin-hydrolase activities. Biochem Biophys Res Commun 101:55Google Scholar
  3. 3.
    Alberts DS, Chen HSG, Mayersohn M, Perrier D, Moon TE, Gross JF (1979) Bleomycin pharmacokinetics in man: II. intracavitary administration. Cancer Chemother Pharmacol 2:127Google Scholar
  4. 4.
    Aszalos A, Crawford J, Vollmer P, Kantor N, Alexander T (1981) High-performance liquid chromatographic determination of components of bleomycin. J Pharm Sci 70:878Google Scholar
  5. 5.
    Bedrossian CWM, Luna MA, Mackay B, Lichtiger B (1973) Ultrastructure of bleomycin toxicity. Cancer 32:44Google Scholar
  6. 6.
    Berry MN, Friend DS (1969) High-yield preparation of isolated rat liver parenchymal cells. A biochemical and fine structure study. J Cell Biol 43:506Google Scholar
  7. 7.
    Blum RH, Carter SK, Agre K (1973) A clinical review of bleomycin: a new antineoplastic agent. Cancer 31:903Google Scholar
  8. 8.
    Broughton A, Strong JE (1976) Radioimmunoassay of bleomycin. Cancer Res 36:1418Google Scholar
  9. 9.
    Comis RL, Kuppinger MS, Ginsberg SJ, Crooke ST, Gilbert R, Auchincloss JH, Prestayko AW (1979) Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patients. Cancer Res 39:5076Google Scholar
  10. 10.
    Crooke ST, Bradner WT (1977) Bleomycin, a review. J Med 7:373Google Scholar
  11. 11.
    De Lena M, Guzzon A, Monfardini S, Bonadonna G (1972) Clinical radiological and histopathological studies on pulmonary toxicity induced by treatment with bleomycin (NSC-125 066). Cancer Treat Rep 56:343Google Scholar
  12. 12.
    Henichart JP, Bernier JL, Helbecque N, Houssin R (1985) Is the bithiazole moiety of bleomycin a classical intercalator. Nucleic Acids Res 13:6703Google Scholar
  13. 13.
    Henichart JP, Bernier JL, Houssin R, Lohez M, Kenani A, Catteau JP (1985) Copper(II)- and iron(II)-complexes of methyl 2-(2-aminoethyl)-aminomethyl-pyridine-6-carboxyl histidinate (AMP His), a peptide mimicking the metal-chelating moiety of bleomycin. An ESR investigation. Biochem Biophys Res Commun 126:1036Google Scholar
  14. 14.
    Iqbal ZM, Kohn KW, Ewig RAG, Fornace AJ (1976) Single strand scission and repair of DNA in mammalian cells by bleomycin. Cancer Res 36:3834Google Scholar
  15. 15.
    Israel L, Breau JL, Morere JF, Aquielera J, Khon M (1986) Induction de réponses objectives par une chimiothérapie anticancéreuse fondée sur l'association prolongée de bléomycine et de cisplatine. Presse Med 25:1183Google Scholar
  16. 16.
    Klett RP, Chovan JP (1985) Modification of a new high-performance liquid chromatography method for bleomycin to separate epi-, iso-, desamido and unmodified analogues. J Chromatogr 337:182Google Scholar
  17. 17.
    Klett RP, Chovan JP, Raisfeld-Danse IH (1984) Reversed-phase paired-ion high-performance liquid chromatographic method for the separation and quantification of multiple bleomycin congeners. J Chromatogr 310:361Google Scholar
  18. 18.
    Krack G, Goethals F, Deboyser D, Roberfroid M (1980) Interference of chemicals with glycogen metabolism in isolated hepatocytes. Toxicology 18:213Google Scholar
  19. 19.
    Krack G, Gravier O, Roberfroid M, Mercier M (1980) Subcellular fractionation of isolated rat hepatocytes. A comparison with liver homogenate. Biochim Biophys Acta 632:619Google Scholar
  20. 20.
    Lazo JS, Humphreys CJ (1983) Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity. Proc Natl Acad Sci USA 80:3064Google Scholar
  21. 21.
    Lazo JS, Boland CJ, Schwartz PE (1982) Bleomycin hydrolase activity and cytotoxicity in human tumors. Cancer Res 42:4026Google Scholar
  22. 22.
    Lazo JS, Merill WW, Pham ET, Lynch TJ, McCallister JD, Ingbar DH (1984) Bleomycin hydrolase activity in pulmonary cells. J Pharmacol Exp Ther 231:583Google Scholar
  23. 23.
    Miyaki M, Ono T, Hori S, Umezawa H (1975) Binding of bleomycin to DNA in bleomycin-sensitive and bleomycin-resistant rat ascites hepatoma cells. Cancer Res 35:2015Google Scholar
  24. 24.
    Muraoka Y (1979) Liquid chromatography of bleomycin. In: Hecht SM (ed) Bleomycin: chemical, biochemical and biological aspects. Springer, New York Berlin Heidelberg, p 92Google Scholar
  25. 25.
    Paladine W, Cunningham TJ, Sponzo R, Donavan M, Olson K, Horton S (1976) Intracavitary bleomycin in the management of malignant effusion. Cancer 38:1903Google Scholar
  26. 26.
    Sakai TT (1978) Paired-ion high-performance liquid chromatography of bleomycins. J Chromatogr 161:389Google Scholar
  27. 27.
    Sebti SM, Lazo JS (1987) Separation of the protective enzyme bleomycin hydrolase from rabbit pulmonary aminopeptidases. Biochemistry 26:432Google Scholar
  28. 28.
    Seki T, Muraoka Y, Takahashi K, Horinishi H, Umezawa H (1985) Radioimmunoassay of bleomycins. J Antibiot 38:1251Google Scholar
  29. 29.
    Shiu GK, Goehl TJ (1980) High-performance paired-ion liquid chromatography determination of bleomycin A2 in urine. J Chromatogr 181:127Google Scholar
  30. 30.
    Shiu GK, Goehl TJ, Pitlick WH (1979) Rapid high-performance liquid chromatographic determination of bleomycin A2 in plasma. J Pharm Sci 68:232Google Scholar
  31. 31.
    Suzuki H, Nagai K, Yamaki H, Tanaka N, Umezawa H (1969) On the mechanism of action of bleomycin-scission of DNA strands in vitro and in vivo. J Antibiot 22:446Google Scholar
  32. 32.
    Umezawa H, Maeda K, Takeuchi T, Okami Y (1966) New antibiotics, bleomycins A and B. J Antibiot 19:200Google Scholar
  33. 33.
    Umezawa H, Suhara Y, Takita T, Maeda K (1966) Purification of bleomycins. J Antibiot 19:210Google Scholar
  34. 34.
    Umezawa H, Takeuchi T, Hori S, Sawa T, Ishizuka M, Ichikawa T, Komai T (1972) Studies on the mechanism of the anti-tumor effect of bleomycin on squamous cell carcinoma. J Antibiot 25:409Google Scholar
  35. 35.
    Umezawa H, Hori S, Sawa T, Yoshioka T, Takeuchi T (1974) A bleomycin-inactivating enzyme in mouse liver. J Antibiot 27:419Google Scholar
  36. 36.
    Yee GC, Crom WR, Brodeur GM, Champion JE, Gutierrez ML, Lee FH, Evans WE (1983) Bleomycin disposition in children with cancer. Clin Pharmacol Ther 33:668Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • Rachid Mahdadi
    • 1
  • Abdelraouf Kenani
    • 2
  • Nicole Pommery
    • 1
  • Jean Pommery
    • 1
  • Jean Pierre Hénichart
    • 2
  • Michel Lhermitte
    • 1
    • 2
  1. 1.Laboratoire de ToxicologieFaculté de Pharmacie de Lille IILille CedexFrance
  2. 2.Unité INSERMLille CedexFrance

Personalised recommendations